IMMUTEP Ltd
IMMP Nasdaq Pharmaceutical Preparations Financials FY2017โFY2026
Revenue
Total sales reported in the income statement.
$16.4M
144.9%
vs prior year
Operating margin
Operating income as a share of revenue.
โ
Net income
Profit after all expenses, interest and tax.
โ$53.7M
Free cash flow
Cash from operations minus capital spending.
โ$37.7M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ
Market cap
Last close times the latest diluted share count, so it is approximate.
โ
P/E
Last close divided by diluted earnings per share over the last four quarters.
โ
On โ$7.30 EPS (TTM)
What IMMUTEP Ltd does
No business description yet.
- Legal name
- IMMUTEP Ltd
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 20-F ยท Oct 23, 2026
- Accession ยท CIK
- 0001193125-26-429413
0001506184
Revenue and margins
IMMUTEP Ltd had $16.4M of revenue in fiscal 2026, up 144.9% on the year before.
FY17
Revenue $3.2M
FY18
Revenue $5.7M
FY19
Revenue $5.4M
FY20
Revenue $11.1M
FY21
Revenue $3.0M
FY22
Revenue $4.9M
FY23
Revenue $3.5M
FY24
Revenue $5.1M
FY25
Revenue $6.7M
FY26
Revenue $16.4M
FY17
Gross โ
Operating โ
Net โ221.9%
FCF โ201.7%
FY18
Gross โ
Operating โ
Net โ173.3%
FCF โ105.9%
FY19
Gross โ
Operating โ
Net โ244.9%
FCF โ204.7%
FY20
Gross โ
Operating โ
Net โ81.6%
FCF โ65.8%
FY21
Gross โ
Operating โ
Net โ753.6%
FCF โ445.0%
FY22
Gross โ
Operating โ
Net โ476.6%
FCF โ447.7%
FY23
Gross โ
Operating โ
Net โ767.2%
FCF โ681.5%
FY24
Gross โ
Operating โ
Net โ544.9%
FCF โ444.6%
FY25
Gross โ
Operating โ
Net โ594.6%
FCF โ601.0%
FY26
Gross โ
Operating โ
Net โ328.1%
FCF โ229.9%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY17
Net income โ$7.1M
FY18
Net income โ$9.9M
FY19
Net income โ$13.1M
FY20
Net income โ$9.0M
FY21
Net income โ$22.3M
FY22
Net income โ$23.4M
FY23
Net income โ$26.8M
FY24
Net income โ$28.0M
FY25
Net income โ$39.8M
FY26
Net income โ$53.7M
FY17
Diluted EPS โ$60.32
FY18
Diluted EPS โ$717.52
FY19
Diluted EPS โ$756.54
FY20
Diluted EPS โ$4.36
FY21
Diluted EPS โ$7.50
FY22
Diluted EPS โ$5.50
FY23
Diluted EPS โ$6.02
FY24
Diluted EPS โ$4.66
FY25
Diluted EPS โ$5.46
FY26
Diluted EPS โ$7.30
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY17
Return on capital โ
Return on equity โ34.6%
Return on assets โ26.3%
FY18
Return on capital โ
Return on equity โ43.8%
Return on assets โ32.1%
FY19
Return on capital โ
Return on equity โ62.7%
Return on assets โ41.6%
FY20
Return on capital โ
Return on equity โ45.2%
Return on assets โ29.9%
FY21
Return on capital โ
Return on equity โ57.4%
Return on assets โ47.8%
FY22
Return on capital โ
Return on equity โ39.1%
Return on assets โ35.5%
FY23
Return on capital โ
Return on equity โ34.6%
Return on assets โ31.9%
FY24
Return on capital โ
Return on equity โ25.9%
Return on assets โ24.1%
FY25
Return on capital โ
Return on equity โ36.2%
Return on assets โ33.6%
FY26
Return on capital โ
Return on equity โ78.9%
Return on assets โ67.2%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was โ$37.7M in fiscal 2026, โ229.9% of revenue. Cash from operations minus capital spending.
FY17
Free cash flow โ$6.4M
FY18
Free cash flow โ$6.0M
FY19
Free cash flow โ$11.0M
FY20
Free cash flow โ$7.3M
FY21
Free cash flow โ$13.2M
FY22
Free cash flow โ$21.9M
FY23
Free cash flow โ$23.8M
FY24
Free cash flow โ$22.8M
FY25
Free cash flow โ$40.2M
FY26
Free cash flow โ$37.7M
FY17
Cash from operations โ$6.4M
Capital spending $0.0M
FY18
Cash from operations โ$6.0M
Capital spending $0.0M
FY19
Cash from operations โ$10.9M
Capital spending $0.0M
FY20
Cash from operations โ$7.3M
Capital spending $0.0M
FY21
Cash from operations โ$13.2M
Capital spending $0.0M
FY22
Cash from operations โ$21.9M
Capital spending $0.0M
FY23
Cash from operations โ$23.8M
Capital spending $0.1M
FY24
Cash from operations โ$22.8M
Capital spending $0.0M
FY25
Cash from operations โ$40.2M
Capital spending $0.0M
FY26
Cash from operations โ$37.6M
Capital spending $0.1M
Cash from operations
Capital spending
Dividends, buybacks and share count
IMMUTEP Ltd returned โ to shareholders in fiscal 2026. The diluted share count rose 1.1%.
FY17
Dividends โ
Buybacks โ
FY18
Dividends โ
Buybacks โ
FY19
Dividends โ
Buybacks โ
FY20
Dividends โ
Buybacks โ
FY21
Dividends โ
Buybacks โ
FY22
Dividends โ
Buybacks โ
FY23
Dividends โ
Buybacks โ
FY24
Dividends โ
Buybacks โ
FY25
Dividends โ
Buybacks โ
FY26
Dividends โ
Buybacks โ
Dividends
Buybacks
FY17
Diluted shares 0.01B
FY18
Diluted shares 0.00B
FY19
Diluted shares 0.00B
FY20
Diluted shares 0.00B
FY21
Diluted shares 0.00B
FY22
Diluted shares 0.00B
FY23
Diluted shares 0.00B
FY24
Diluted shares 0.01B
FY25
Diluted shares 0.01B
FY26
Diluted shares 0.01B
Balance sheet
Cash, debt and the ratios that show how comfortably IMMUTEP Ltd can carry it.
FY17
Cash $9.4M
Debt โ
FY18
Cash $17.3M
Debt โ
FY19
Cash $11.6M
Debt โ
FY20
Cash $18.0M
Debt โ
FY21
Cash $45.4M
Debt โ
FY22
Cash $55.0M
Debt โ
FY23
Cash $81.8M
Debt โ
FY24
Cash $108M
Debt โ
FY25
Cash $44.0M
Debt โ
FY26
Cash $43.9M
Debt โ
Cash
Debt
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $55.0M | $81.8M | $108M | $44.0M | $43.9M |
| Current ratio | 14.2x | 13.8x | 18.2x | 11.7x | 5.7x |
| Quick ratio | 14.2x | 13.8x | 18.2x | 11.7x | 5.7x |
| Total assets | $70.3M | $97.7M | $134M | $103M | $57.3M |
| Total liabilities | $5.6M | $7.3M | $8.0M | $8.7M | $15.0M |
| Shareholders' equity | $64.7M | $90.4M | $126M | $93.8M | $42.4M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 4 / 7 | 2 / 7 | 4 / 7 | 2 / 7 | 4 / 7 | 2 / 7 | 4 / 7 | 1 / 7 | 2 / 7 |
| Accruals ratio | โ2.4% | โ12.5% | โ6.9% | โ5.8% | โ19.6% | โ2.2% | โ3.6% | โ4.5% | 0.3% | โ20.2% |
| Altman Z'' | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.2M | $5.7M | $5.4M | $11.1M | $3.0M | $4.9M | $3.5M | $5.1M | $6.7M | $16.4M |
| Research and development | $5.7M | $7.7M | $9.8M | $10.4M | $9.0M | $18.4M | $19.4M | $20.6M | $32.2M | $51.9M |
| Interest expense | โ | โ | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Pretax income | โ$7.6M | โ$9.9M | โ$13.1M | โ$9.0M | โ$22.3M | โ$23.4M | โ$26.8M | โ$28.0M | โ$39.8M | โ$53.7M |
| Income tax | โ$0.6M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | โ$7.1M | โ$9.9M | โ$13.1M | โ$9.0M | โ$22.3M | โ$23.4M | โ$26.8M | โ$28.0M | โ$39.8M | โ$53.7M |
| Net income to common | โ$7.1M | โ$9.9M | โ$13.1M | โ$9.0M | โ$22.3M | โ$23.4M | โ$26.8M | โ$28.0M | โ$39.8M | โ$53.7M |
| Diluted EPS | โ$60.32 | โ$717.52 | โ$756.54 | โ$4.36 | โ$7.50 | โ$5.50 | โ$6.02 | โ$4.66 | โ$5.46 | โ$7.30 |
| Diluted shares | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | โ$6.4M | โ$6.0M | โ$10.9M | โ$7.3M | โ$13.2M | โ$21.9M | โ$23.8M | โ$22.8M | โ$40.2M | โ$37.6M |
| Capital expenditure | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.1M |
| Free cash flow | โ$6.4M | โ$6.0M | โ$11.0M | โ$7.3M | โ$13.2M | โ$21.9M | โ$23.8M | โ$22.8M | โ$40.2M | โ$37.7M |
| Depreciation and amortization | $1.3M | $1.4M | $1.3M | $1.4M | $1.5M | $1.5M | $1.4M | $1.5M | $1.5M | $1.7M |
| Stock-based compensation | $0.7M | $1.8M | $1.1M | $1.2M | $1.3M | $1.1M | $1.3M | $1.2M | $0.8M | $1.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $9.4M | $17.3M | $11.6M | $18.0M | $45.4M | $55.0M | $81.8M | $108M | $44.0M | $43.9M |
| Current assets | $12.2M | $21.2M | $16.5M | $21.3M | $51.3M | $62.5M | $89.4M | $127M | $97.4M | $55.5M |
| Current liabilities | $2.0M | $2.8M | $3.7M | $2.3M | $4.0M | $4.4M | $6.5M | $7.0M | $8.3M | $9.8M |
| Property and equipment, net | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.1M |
| Total assets | $26.9M | $34.7M | $28.4M | $31.9M | $61.5M | $70.3M | $97.7M | $134M | $103M | $57.3M |
| Total liabilities | $6.5M | $10.0M | $11.3M | $9.1M | $6.6M | $5.6M | $7.3M | $8.0M | $8.7M | $15.0M |
| Shareholders' equity | $20.4M | $24.8M | $17.1M | $22.8M | $54.9M | $64.7M | $90.4M | $126M | $93.8M | $42.4M |
| Margins | ||||||||||
| Net margin | โ221.9% | โ173.3% | โ244.9% | โ81.6% | โ753.6% | โ476.6% | โ767.2% | โ544.9% | โ594.6% | โ328.1% |
| FCF margin | โ201.7% | โ105.9% | โ204.7% | โ65.8% | โ445.0% | โ447.7% | โ681.5% | โ444.6% | โ601.0% | โ229.9% |
| Returns | ||||||||||
| Return on equity | โ34.6% | โ43.8% | โ62.7% | โ45.2% | โ57.4% | โ39.1% | โ34.6% | โ25.9% | โ36.2% | โ78.9% |
| Return on assets | โ26.3% | โ32.1% | โ41.6% | โ29.9% | โ47.8% | โ35.5% | โ31.9% | โ24.1% | โ33.6% | โ67.2% |
| Return on tangible equity | โ34.6% | โ39.9% | โ76.8% | โ39.6% | โ40.6% | โ36.1% | โ29.7% | โ22.2% | โ42.4% | โ126.8% |
| Growth | ||||||||||
| Revenue growth | โ | 79.0% | โ6.0% | 106.4% | โ73.2% | 65.6% | โ28.7% | 46.9% | 30.1% | 144.9% |
| Share count change | โ | โ88.4% | 26.1% | 19.0% | 44.1% | 42.7% | 5.1% | 34.6% | 21.2% | 1.1% |
| Financial health | ||||||||||
| Current ratio | 6.0x | 7.4x | 4.4x | 9.3x | 12.8x | 14.2x | 13.8x | 18.2x | 11.7x | 5.7x |
| Quick ratio | 6.0x | 7.4x | 4.4x | 9.3x | 12.8x | 14.2x | 13.8x | 18.2x | 11.7x | 5.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | 0.2% | 0.6% | 0.1% | 0.4% | 0.3% | 1.6% | 0.4% | 0.4% | 0.4% |
| Stock comp / revenue | 20.4% | 30.8% | 21.1% | 10.5% | 42.9% | 22.0% | 38.5% | 22.9% | 11.3% | 6.6% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 4.0 | 2.0 | 4.0 | 2.0 | 4.0 | 2.0 | 4.0 | 1.0 | 2.0 |
| Accruals ratio | โ2.4% | โ12.5% | โ6.9% | โ5.8% | โ19.6% | โ2.2% | โ3.6% | โ4.5% | 0.3% | โ20.2% |
Source: SEC EDGAR XBRL filings (CIK 0001506184). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in AUD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 200 ordinary shares). For information only โ not investment advice. Check the original filings before relying on any figure.